LICHEN planusTERMINATION of treatmentACADEMIC medical centersHAIR folliclesHYDROXYCHLOROQUINEBackground: Lichen planopilaris (LPP) is an inflammatory cicatricial alopecia characterized by an irreversible destruction of the hair follicle resulting in its permeant destruction. The clinical presentation of LPP...
Lichen planopilaris (LPP) is an inflammatory cicatricial alopecia for which many different therapies are attempted with varying success. The Janus kinase (JAK) inhibitor, tofacitinib, has been shown to be effective in treating the noncicatricial alopecia, alopecia areata. As in alopecia areata, upre...
Intoduction: Lichen planopilaris is an inflammatory lymphocyte mediated disorder in which INF-γ pathway fulfills an important role. Since JAKs are involved in the transduction of INF-γ signals their inhibition may be a good target for LPP treatment. Data on the efficacy of JAK-inhibitors on LP...
Lichen Planopilaris: Causes, Symptom, and Treatment RichFeel Lichen Planopilaris is a chronic inflammatory condition that affects the scalp. It results in patches ofhair losson the scalp that may cause itching and burning. Lichen Planopilaris is a form of lichen planus that mostly affects women ...
Commentary: treatment of lichen planopilaris, some progress, but a long way to go. J Am Acad Dermatol. 2010;62(3):387–93.Sperling LC, Nguyen JV. Commentary: treatment of lichen planopilaris, some progress, but a long way to go. J Am Acad ...
Introduction: Lichen planopilaris (LPP) is one of the most common causes of scarring hair loss caused by immune‐mediated inflammation resulting in atrophy and scaling. The key to preventing this irreversible hair loss is diagnosing and starting treatment at the earliest possible stag...
lichen planopilarisscarring alopeciatofacitinibJanus kinase family (JAKs) has recently attracted the attention of many researchers, and several JAK inhibitor drugs have been developed targeting different members of the JAK family. Tofacitinib and ruxolitinib are U.S. FDA approved drugs in this family ...
LB1667 Successful treatment of rare linear lichen planopilaris with ixekizumabAbstractdoi:10.1016/j.jid.2023.06.039H. AhmedHamad Medical Corporation, Doha, Ad Dawhah, QatarM. PetkarHamad Medical Corporation, Doha, Ad Dawhah, QatarM. Steinhoff
Lichen planopilaris (LPP) is an immune-mediated cicatricial alopecia. The main clinical presentations of LPP include classic form, frontal fibrosing alopecia (FFA), and Graham-Little-Piccardi-Lassueur syndrome (GLPLS). We reviewed medical records of all 291 patients diagnosied with LPP from 2006...
Lichen planopilaris (LPP) is characterized by lymphocytic infiltrate, fibrosis and potential destruction of the hair follicle. Demographic and clinical studies in LPP are limited, and racial differences have not been thoroughly investigated.To analyse epidemiological data and clinical profiles of Chilean ...